By Kathryn DeMott, National Eye Institute A therapy designed to prevent blindness in people with the inherited neurodegenerative disorder spinocerebellar ataxia type 7 (SCA-7) is nearing the launch pad for testing in clinical trials, said Dr. Albert La Spada, director of the Duke University center for Neurodegeneration & Neurotherapeutics. La Spada, who is spearheading the …
Recent Comments